“Advancements in endograft stent technologies and a shift from open surgical repair to minimal invasive endovascular repair has led to the sizeable market growth.”
The global endovascular aneurysm repair market was pegged at $2.33 billion in 2016 and is estimated to garner at $3.58 billion by 2023, growing at a CAGR of 6.2% from 2017 to 2023.
Rise in adoption of endovascular stent grafts and development of next-generation stent graft and increase in awareness in the emerging economies regarding availability of wide range of aortic aneurysm devices are the major drivers of the global endovascular aneurysm repair market. However, high cost of endovascular aneurysm repair procedures and several risks associated with these procedures hamper the market growth.
Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/1879
The market is divided according to indication, site, anatomy, products, and geography. Based on the indication, the market is segmented into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). The thoracic aortic aneurysm (TAA) segment is estimated to manifest the fastest CAGR of 8.8% during the forecast period, owing to increase in development of sophisticated devices for the treatment of a thoracic aneurysm. However, the abdominal aortic aneurysm (AAA) segment held the largest market share in 2016, contributing nearly half of the market and is expected to maintain its dominance throughout the study period.
On the basis of the site, the market is divided into infrarenal and pararenal. The infrarenal site held the largest share in 2016, contributing about sixth-seventh of the total market, owing to elevated rate of occurrence of abdominal aneurysm at infrarenal site. However, the pararenal site of EVAR segment market is estimated to register the fastest CAGR of 7.1% during the forecast period.
Based on anatomy, the market is segmented into traditional and complex. On the basis of products, the market is divided into percutaneous EVAR, fenestrated EVAR, aortic stents & TAA grafts, and others. The percutaneous EVAR segment is projected to portray the CAGR of 6.9% throughout the forecast period, owing to the increase in demand for advanced technologies, surge in incidence of aneurysm, and rapid surge in geriatric population across the globe.
Based on geography, the market is bifurcated into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (LAMEA). As per the report, Asia-Pacific and LAMEA regions collectively accounted for nearly one-fifth of the total share and is projected to continue this trend through 2023, owing to rise in adoption of endovascular aneurysm repair in the developing countries such as India and China. However, the U.S. was the major shareholder in the North America endovascular aneurysm repair market in 2016.
For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/1879
The report includes in-depth analysis of the major market players such as Medtronic plc., Endologix, Inc., W. L. Gore & Associates, Inc., C. R. Bard, Inc., Terumo Corporation, Cook Medical Inc., Lombard Medical, Inc., Cardinal Health Inc., Merck & Co., Inc., and Abbott Laboratories.
Key Findings of the Endovascular Aneurysm Repair (Evar) Market:
- The pararenal segment is anticipated to grow at a highest rate during the analysis period.
- U.S. was the major shareholder in the North America endovascular aneurysm repair market, accounted for the highest share in 2016.
- The traditional segment occupied about three-fourth share of the total EVAR market by anatomy in 2016 and expected to retain its dominant share throughout the forecast period.
- China occupied two-ninth share of the total Asia-Pacific endovascular aneurysm repair market in 2016, registering a high CAGR of 11.2% from 2017 to 2023.
- The percutaneous EVAR product segment dominated the endovascular aneurysm repair market in 2016, growing at a CAGR of 6.9% from 2017 to 2023.
- The juxtarenal segment accounted for the seventh-ninth share in pararenal site in 2016.
Scope of The Report:
|Market size available for years||2016-2023|
|Base year considered||2017|
|Forecast units||Value (USD)|
|Segments covered||Product, Indication, Site and Anatomy|
|Geographies covered||North America, Europe, Asia-Pacific, LAMEA|
Liquid Biopsy Market by Product & Service (Reagents, Instruments, and Service), Cancer Type (Lung, Breast, Colorectal, Prostate, Liver, and Others), Circulating Biomarker (Circulating Tumor Cells, Extracellular Vesicles, Circulating Tumor DNA [CtDNA], and Other Biomarkers) – Global Opportunity Analysis and Industry Forecast, 2017-2023
Structural Heart Devices Market by Product (Structural Heart Repair Devices and Replacement Valves), Age Group (Pediatric and Adult), and Indication (Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO), Ventricular Septal Defect (VSD), and Aortic Valve Stenosis) – Global Opportunity Analysis and Industry Forecast, 2014-2022
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
Follow Us on Twitter: https://twitter.com/marketresearcht